CareFusion announces acquisition of UK Medical

Technology company, CareFusion, has this week announced the acquisition of UK Medical, a leading provider of healthcare products to the NHS and private sector.

While terms of the deal have not yet been revealed, this is the company’s fifth take-over as part of a global expansion plan.

Commenting on the move, Gordon LaFortune, executive vice president of international commercial operations at CareFusion, said: “The acquisition further strengthens CareFusion’s presence in the UK, where we have built leadership positions in infusion therapy and infection prevention. We believe this acquisition will help us expand our long-standing partnership with UK Medical and better leverage the company’s clinical expertise to continue to grow our procedural solutions business in the UK and beyond.”

UK Medical primarily serves the NHS, focusing on distribution of clinically differentiated interventional and implantable single-use medical products for biopsy, cardiac, drainage, obstetrics and gynaecology, non-vascular stenting, surgery and vertebroplasty. The company also served as the sole UK distributor of CareFusion’s interventional technologies portfolio, including soft-tissue and bone marrow biopsy needles, the AVAmax Advanced Vertebral Augmentation System and the PleurX Peritoneal Catheter Drainage System, which NICE recently supported through published guidance for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites. The company also markets medical products for around 10 additional suppliers.

“For more than 30 years, we have served the NHS and private medical sector with high-quality, high-technology medical products to help improve patient care pathways”, said Jim Mackenzie, chairman of UK Medical.

UK Medical has around 40 employees and is headquartered in Sheffield, while CareFusion currently employs approximately 350 people in the UK.